Lightnews — Scholar-powered news

Urs Weber, MD

@urswebermd.bsky.social

27 followers 45 following 9 posts

Proud 🇩🇪, grew up in 🇩🇪/🇨🇭/🇬🇧/🇪🇸, now living in 🇺🇸. Oncology fellow at CU. Views are my own.

Posts Media Videos Starter Packs

Urs Weber, MD @urswebermd.bsky.social · 4d

It was a pleasure attending and speaking at the 2025 Seattle Lung Cancer Conference. The 🫁 were truly front and center! @binaytara.bsky.social #SeattleLung25

1 1

Urs Weber, MD @urswebermd.bsky.social · Sep 8

Watching @drcamidge.bsky.social navigate this cruel twist of fate for the last few years has been nothing short of inspirational. Becoming a lung cancer patient himself has made him an even better clinician, researcher, and advocate. I’m very fortunate to be able to learn from him.

CU Cancer Center @cucancercenter.bsky.social · Sep 8

A EGFR-mutated advanced non-small cell lung cancer diagnosis has not stopped @drcamidge.bsky.social from continuing his lung cancer research, training the next generation of lung cancer providers, and spending time with his family. https://bit.ly/47yGdBb

#LungCancer #LungCancerFighter‬‬‬

World Lung Cancer Expert Diagnosed with Advanced Lung Cancer

D. Ross Camidge, MD, PhD, has spent his career fighting lung cancer. In 2022, that fight turned personal when he received a diagnosis of his own.

news.cuanschutz.edu

Urs Weber, MD @urswebermd.bsky.social · Jun 25

Last day of clinic at the VA. It’s been an honor taking care of the veterans here for the last 2.5 years. I’ll miss my patients and the team in the hematology/oncology clinic.

Urs Weber, MD @urswebermd.bsky.social · Jun 20

It’s getting real! I’m honored to soon be sharing an office with my mentor at @cucancercenter.bsky.social

Urs Weber, MD @urswebermd.bsky.social · Jun 2

Tarlatamab is clearly the best 2nd line therapy for small cell lung cancer available now. I’m excited to see this and similar agents develop and perhaps move into the 1st line. #ASCO2025

NEJM.org @nejm.org · Jun 2

DeLLphi-304: Among patients with relapsed small-cell lung cancer after the failure of platinum-based chemotherapy, tarlatamab therapy led to a greater overall and progression-free survival benefit over chemotherapy, with fewer severe adverse events. nej.md/3YWiy8O

#ASCO25

Urs Weber, MD @urswebermd.bsky.social · Jun 2

Neoadjuvant treatment with chemo-immunotherapy is clearly the new standard of care for most patients with resectable non-small cell lung cancer. The question remains what (if any) is the best adjuvant therapy for these patients? #ASCO2025

NEJM.org @nejm.org · Jun 2

In non–small-cell lung cancer, three cycles of neoadjuvant nivolumab plus chemotherapy improved 5-year overall survival over chemotherapy alone, with variation according to pathological response. Full CheckMate 816 phase 3 trial results: nej.md/4k6Wlxj

#ASCO25 @ascocancer.bsky.social

Urs Weber, MD @urswebermd.bsky.social · Jun 1

Exercise reduces the risk of cancer recurrence and improves survival after colon cancer treatment. I suspect that this is also true in other cancers. This should be one of the most impactful trials to come out of #ASCO2025!

NEJM.org @nejm.org · Jun 1

Late breaking at #ASCO25:

A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial: nej.md/4mh5RPL

@ascocancer.bsky.social

Urs Weber, MD @urswebermd.bsky.social · Apr 25

I applaud these authors for trying to answer a very tricky question. I don’t quite know what to make of their numbers given the many unknowns and confounders, but I do believe that CTs increase cancer risk and that we could (and probably should) do less of them.

Projected Lifetime Cancer Risks From Current Computed Tomography Imaging

This risk model projects how many future cancers in the United States could result from annual computed tomography examinations.

jamanetwork.com

Urs Weber, MD @urswebermd.bsky.social · Apr 24

@drcamidge.bsky.social have you ever encountered central necrosis in your time in the oncologist’s garden?

1 1